At ASCO Breakthrough 2023, Pictor Labs—in collaboration with the University of Maryland—leverages AI-driven virtual staining technology to rapidly generate multiplex virtual IHC markers (CD3, CD20, and PAX5) from a single unstained tissue, accelerating immune cell phenotyping and tumor analysis.